12-11092022-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_176884.2(TAS2R43):āc.208G>Cā(p.Val70Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000532 in 1,483,660 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_176884.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000565 AC: 7AN: 123788Hom.: 0 Cov.: 22
GnomAD3 exomes AF: 0.0000897 AC: 19AN: 211858Hom.: 4 AF XY: 0.0000779 AC XY: 9AN XY: 115554
GnomAD4 exome AF: 0.0000529 AC: 72AN: 1359872Hom.: 1 Cov.: 60 AF XY: 0.0000441 AC XY: 30AN XY: 679688
GnomAD4 genome AF: 0.0000565 AC: 7AN: 123788Hom.: 0 Cov.: 22 AF XY: 0.0000498 AC XY: 3AN XY: 60264
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 21, 2024 | The c.208G>C (p.V70L) alteration is located in exon 1 (coding exon 1) of the TAS2R43 gene. This alteration results from a G to C substitution at nucleotide position 208, causing the valine (V) at amino acid position 70 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at